Looks like the 0.027-0.030 support, is now our resistance.
Shareholders want to see how many sales or revenue will be generated in the 10Q.
The company said it would be less than $10M, and we know that last year they made $1M+ Revenues.
That is a Huge spread, from $1M to $10M, that needs to be more accurately clarified by the company.
Vaccine sales news should let us recover the 0.03 Support.
Low volume trading until then,... looks like.
imho.